Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use.

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

New research indicates that people with cardiovascular-kidney-metabolic syndrome may have a higher risk of developing ...

Kidney disease is a leading cause of death in America, killing more people than breast cancer or prostate cancer.

People with chronic kidney disease and type 2 diabetes may face heart disease up to 28 years earlier than others.

The FDA rejected sotagliflozin 5 years ago for the same indication but for the broader population of adults with T1D, due to ...

MultiOmic Health, a leading AI-enabled drug discovery company, announces the identification of novel patient endotypes and the development of proprietary biomarkers for stratifying diabetic kidney ...

People with diabetes face a number of health challenges related to their chronic condition, and loss of vision due to retinal ...

As part of its ongoing RAK diabetes Challenge community initiative, RAK Hospital held an insightful Diabeat Webinar on the LINK between diabetes and kidney disease, shedding light on the prevention ...